Gene silencing and mRNA: breakthroughs and barriers – the pharmaphorum podcast
Silence Therapeutics
Podcast/ R&D/ Slider in video/ Video/ Views & Analysis/ Views and analysis
Gene silencing and mRNA: breakthroughs and barriers – the pharmaphorum podcast
Jonah Comstock
COVID-19, gene silencing, gene therapy, mRNA, Silence Therapeutics
0 Comment
Amgen eyes swift move to ph3 for cardiovascular drug olpasiran
Phil Taylor
Amgen, atherosclerosis, gene silencing, lipoprotein(a), Novartis, olpasiran, pelacarsen, Silence Therapeutics, siRNA, SLN360
0 Comment
Silence Tx uses game to raise thalassaemia awareness
Phil Taylor
digital, digital health, Games, rare disease, Silence Therapeutics, thalassaemia
0 Comment
AZ adds gene silencing tech to pipeline with Silence Therapeutics deal
Richard Staines
Alnylam, AstraZeneca, cardiovascular diseases, R&D, Silence Therapeutics, siRNA
0 Comment
Silence Therapeutics takes rival Alnylam to court in patent fight
Richard Staines
Alnylam, Biotech, litigation, patent, Silence Therapeutics
0 Comment
Silence claims late-stage drugs infringe patents.